These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 31921729)

  • 1. Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease.
    Zhao Y; Zhou J; Liu J; Wang Z; Chen M; Zhou S
    Front Pediatr; 2019; 7():518. PubMed ID: 31921729
    [No Abstract]   [Full Text] [Related]  

  • 2. The relationship of Megamonas species with nonalcoholic fatty liver disease in children and adolescents revealed by metagenomics of gut microbiota.
    Zhou J; Zhang Q; Zhao Y; Zou Y; Chen M; Zhou S; Wang Z
    Sci Rep; 2022 Dec; 12(1):22001. PubMed ID: 36539432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota Dysbiosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study in Taiwan.
    Tsai MC; Liu YY; Lin CC; Wang CC; Wu YJ; Yong CC; Chen KD; Chuah SK; Yao CC; Huang PY; Chen CH; Hu TH; Chen CL
    Nutrients; 2020 Mar; 12(3):. PubMed ID: 32204538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of intestinal flora in the development of nonalcoholic fatty liver disease in children.
    Zhang J; Shi M; Zhao C; Liang G; Li C; Ge X; Pei C; Kong Y; Li D; Yang W; Cao B; Fu L; Yan Y; Wu J; Zhou J; Fang Y; Meng X; Li Y; Wang L
    Microbiol Spectr; 2024 Feb; 12(2):e0100623. PubMed ID: 38189294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Correlation analysis of gut microbiota and biochemical indexes in patients with non-alcoholic fatty liver disease].
    Ren SM; Mei L; Huang H; Cao SF; Zhao RH; Zheng PY
    Zhonghua Gan Zang Bing Za Zhi; 2019 May; 27(5):369-375. PubMed ID: 31177662
    [No Abstract]   [Full Text] [Related]  

  • 7. Disease-Associated Gut Microbiota Reduces the Profile of Secondary Bile Acids in Pediatric Nonalcoholic Fatty Liver Disease.
    Yu J; Zhang H; Chen L; Ruan Y; Chen Y; Liu Q
    Front Cell Infect Microbiol; 2021; 11():698852. PubMed ID: 34568090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific Strains of
    Hu W; Gao W; Liu Z; Fang Z; Wang H; Zhao J; Zhang H; Lu W; Chen W
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Microbiota, Glucose, Lipid, and Water-Electrolyte Metabolism in Children With Nonalcoholic Fatty Liver Disease.
    Pan X; Kaminga AC; Liu A; Wen SW; Luo M; Luo J
    Front Cell Infect Microbiol; 2021; 11():683743. PubMed ID: 34778099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant decrease in Faecalibacterium among gut microbiota in nonalcoholic fatty liver disease: a large BMI- and sex-matched population study.
    Iino C; Endo T; Mikami K; Hasegawa T; Kimura M; Sawada N; Nakaji S; Fukuda S
    Hepatol Int; 2019 Nov; 13(6):748-756. PubMed ID: 31515740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut Microbiota Profile Changes in Patients with Inflammatory Bowel Disease and Non-Alcoholic Fatty Liver Disease: A Metagenomic Study.
    De Caro C; Spagnuolo R; Quirino A; Mazza E; Carrabetta F; Maurotti S; Cosco C; Bennardo F; Roberti R; Russo E; Giudice A; Pujia A; Doldo P; Matera G; Marascio N
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota dysbiosis in patients with non-alcoholic fatty liver disease.
    Shen F; Zheng RD; Sun XQ; Ding WJ; Wang XY; Fan JG
    Hepatobiliary Pancreat Dis Int; 2017 Aug; 16(4):375-381. PubMed ID: 28823367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease.
    Liang T; Li D; Zunong J; Li M; Amaerjiang N; Xiao H; Khattab NM; Vermund SH; Hu Y
    Nutrients; 2022 Nov; 14(21):. PubMed ID: 36364902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Hypocaloric Hyperproteic Diet on Gut Microbiota in Overweight or Obese Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study.
    Pataky Z; Genton L; Spahr L; Lazarevic V; Terraz S; Gaïa N; Rubbia-Brandt L; Golay A; Schrenzel J; Pichard C
    Dig Dis Sci; 2016 Sep; 61(9):2721-31. PubMed ID: 27142672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diammonium Glycyrrhizinate Protects against Nonalcoholic Fatty Liver Disease in Mice through Modulation of Gut Microbiota and Restoration of Intestinal Barrier.
    Li Y; Liu T; Yan C; Xie R; Guo Z; Wang S; Zhang Y; Li Z; Wang B; Cao H
    Mol Pharm; 2018 Sep; 15(9):3860-3870. PubMed ID: 30036479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut Microbiota of Chinese Obese Children and Adolescents With and Without Insulin Resistance.
    Yuan X; Chen R; Zhang Y; Lin X; Yang X; McCormick KL
    Front Endocrinol (Lausanne); 2021; 12():636272. PubMed ID: 33815293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease.
    Michail S; Lin M; Frey MR; Fanter R; Paliy O; Hilbush B; Reo NV
    FEMS Microbiol Ecol; 2015 Feb; 91(2):1-9. PubMed ID: 25764541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of gut dominant microbiota in obese patients with nonalcoholic fatty liver disease.
    Jin LT; Xu MZ
    Front Cell Infect Microbiol; 2023; 13():1113643. PubMed ID: 36756620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut Microbiota and Non-Alcoholic Fatty Liver Disease Severity in Type 2 Diabetes Patients.
    Tsai HJ; Tsai YC; Hung WW; Hung WC; Chang CC; Dai CY
    J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33807075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.